Dialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion

Central Venous Catheter Thrombosis Clinical Trial

Official title:

Dialysis Catheter Placement in Patients With Thoracic Central Venous Occlusion

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03766828
• Other study ID #: Vienna-DialysisAccess
• Status: Completed
• Start date: September 1, 2016
• Est. completion date: June 30, 2018

Study information

• Verified date: May 2019
• Source: Medical University of Vienna
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A unique inside-out-access technique with a new CE certified device (Surfacer (R) Bluegrass Vascular, San Antonio, Tx, USA) enables repetitive and confident right-sided placement of central venous catheters in hemodialysis patients with thoracic central venous occlusion.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 36
• Est. completion date: June 30, 2018
• Est. primary completion date: June 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients with thoracic central venous occlusion

Exclusion Criteria:

• pregnancy

Related Conditions & MeSH terms

• Central Venous Catheter Thrombosis
• Thrombosis
• Upper Extremity Deep Vein Thrombosis

Intervention

Procedure:
• inside-out-access technique with inside-out access device (Surfacer (R))
inside-out-access technique with (Surfacer (R)) with a new CE certified device (Surfacer (R), Bluegrass Vascular)
• access technique including Sharp recanalization
access technique with Sharp recanalization via interventional radiology

Locations

Country	Name	City	State
Austria	Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna	Vienna

Sponsors (1)

Lead Sponsor	Collaborator
Medical University of Vienna

Country where clinical trial is conducted

Austria, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Achievement of dialysis access		1 day
Secondary	procedure related complications	infections, bleeding, hematoma or pericardial effusions and intervention related parameters	3 months